Affiliation:
1. Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
Abstract
Introduction:
Pituitary stalk interruption syndrome (PSIS) is featured by hypopituitarism and
a classic triad of absence or slender pituitary stalk, absence or ectopic posterior lobe, and hypoplasia of
the anterior lobe. Hypopituitarism, which induces hormone deficiencies, is associated with non-alcoholic
fatty liver disease (NAFLD) and liver cirrhosis.
Case Presentation:
A 29-year-old male patient was presented with intermittent nosebleeds and underdeveloped
secondary sexual characteristics. Laboratory examination revealed low gonadal hormone,
thyroxine, and cortisol levels. Magnetic resonance imaging revealed an interrupted pituitary stalk, ectopic
posterior pituitary, and hypoplastic anterior pituitary. PSIS was confirmed. Liver cirrhosis was
supported by bilirubin metabolism disorder, abnormal coagulation, the varicose vein of the esophagus
and fundus of the stomach, hypersplenism, and signs on a computer tomography scan. He received
glucocorticoid, levothyroxine, androgen, and human chorionic gonadotropin supplements, and growth
hormone was not given because of poverty. Five months later, the patient developed Cushing-like
symptoms and further deterioration of liver function.
Conclusion:
PSIS can cause liver impairment and even cirrhosis, which may be associated with multiple
hormone deficiencies. A case of PSIS with cirrhosis as the initial symptom and progression of cirrhosis
in the absence of growth hormone (GH) therapy suggests that GH therapy may be important in
PSIS-related cirrhosis.
Publisher
Bentham Science Publishers Ltd.
Subject
Immunology and Allergy,Endocrinology, Diabetes and Metabolism
Reference41 articles.
1. Wang W.; Wang S.; Jiang Y.; Yan F.; Su T.; Zhou W.; Jiang L.; Zhang Y.; Ning G.; Relationship between pituitary stalk (PS) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited. Clin Endocrinol 2015,83(3),369-376
2. Han B.Y.; Zhang Q.; Li L.L.; Guo Q.H.; Wang C.Z.; Cang L.; Jin N.; Chen F.; Zhao L.; Cui J.; Gu X.L.; Ma F.L.; Zhang S.C.; Mu Y.M.; Dou J.T.; Clinical features of pituitary stalk interruption syndrome in 114 cases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2016,38(5),534-538
3. Hong J.W.; Kim J.Y.; Kim Y.E.; Lee E.J.; Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. Horm Metab Res 2011,43(1),48-54
4. Yuan X.X.; Zhu H.J.; Pan H.; Chen S.; Liu Z.Y.; Li Y.; Wang L.J.; Lu L.; Yang H.B.; Gong F.Y.; Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. World J Gastroenterol 2019,25(14),1741-1752
5. Adams L.A.; Feldstein A.; Lindor K.D.; Angulo P.; Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 2004,39(4),909-914
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献